• Opinion
• [Reporter’s View] Postponing clinical reevaluations by 1 yr
• by Lee, Tak-Sun Jul 18, 2022 06:05am

• Opinion
• [Reporter's view] The 2nd Danaher, SD BioSensor
• by Jul 13, 2022 06:05am

• Opinion
• [Reporter’s View] COVID-19 trials still in smooth progress?
• by Kim, Jin-Gu Jul 8, 2022 06:25am

• Opinion
• [Reporter's view] Revlimid passed the committee
• by Eo, Yun-Ho Jul 6, 2022 05:47am

• Opinion
• [Reporter's view] Looking forward to another K-COVID vaccine
• by Lee, Hye-Kyung Jul 4, 2022 05:55am

• Opinion
• [Reporter's view] Negotiation of Zolgensma
• by Jun 30, 2022 05:52am

• Opinion
• [Reporter's view] Only 2% of patients
• by Eo, Yun-Ho Jun 23, 2022 05:50am

• Opinion
• [Reporter's view]Will arbitrary manufacturing be eradicated?
• by Kim, Jin-Gu Jun 8, 2022 05:56am

• Opinion
• [Reporter’s View] Differing indication and reimb standards
• by Eo, Yun-Ho Jun 2, 2022 05:58am

• Opinion
• [Reporter’s view] What was gained and lost with COVID R&D
• by Kim, Jin-Gu May 25, 2022 05:47am